DK137392B - Fremgangsmade til fremstilling af en koppebeskyttelsesvaccine i form af svekket vaccinia-vira til brug ved forvaccination inden den egentlige koppevaccination - Google Patents

Fremgangsmade til fremstilling af en koppebeskyttelsesvaccine i form af svekket vaccinia-vira til brug ved forvaccination inden den egentlige koppevaccination

Info

Publication number
DK137392B
DK137392B DK447972AA DK447972A DK137392B DK 137392 B DK137392 B DK 137392B DK 447972A A DK447972A A DK 447972AA DK 447972 A DK447972 A DK 447972A DK 137392 B DK137392 B DK 137392B
Authority
DK
Denmark
Prior art keywords
prevaccination
vira
vaccination
procedure
preparation
Prior art date
Application number
DK447972AA
Other languages
English (en)
Other versions
DK137392C (da
Inventor
A H Stickl
Original Assignee
Freistaat Bayern Vertreten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712145477 external-priority patent/DE2145477C3/de
Application filed by Freistaat Bayern Vertreten filed Critical Freistaat Bayern Vertreten
Publication of DK137392B publication Critical patent/DK137392B/da
Application granted granted Critical
Publication of DK137392C publication Critical patent/DK137392C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK447972A 1971-09-11 1972-09-11 Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination DK137392C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712145477 DE2145477C3 (de) 1971-09-11 Impfstoff für die intracutane Pockenschutzimpfung

Publications (2)

Publication Number Publication Date
DK137392B true DK137392B (da) 1978-02-27
DK137392C DK137392C (da) 1978-09-18

Family

ID=5819271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK447972A DK137392C (da) 1971-09-11 1972-09-11 Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination

Country Status (5)

Country Link
AT (1) AT320149B (da)
BE (1) BE787901A (da)
CH (1) CH568392A5 (da)
DK (1) DK137392C (da)
ES (1) ES406590A1 (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152745B (da) * 1977-04-01 1988-05-09 Anton Mayr Fremgangsmaade ved fremstilling af et praeparat til behandling af herpes zoster og andre herpesinfektioner

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
EP2264178A1 (en) 2002-08-07 2010-12-22 Bavarian Nordic A/S Vaccinia virus host range genes to increase the titer of Avipoxviruses
EP2363143A3 (en) 2003-03-28 2012-02-15 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services MVA expressing modified hiv envelope, gag, and pol genes
EP2319860A3 (en) 2004-08-27 2011-06-15 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes
CA2676149C (en) 2007-05-14 2016-06-21 Bavarian Nordic A/S Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
SG178909A1 (en) 2009-10-08 2012-04-27 Bavarian Nordic As Generation of a broad t-cell response in humans against hiv
AU2011281982B2 (en) 2010-07-20 2015-12-17 Bavarian Nordic A/S Method for harvesting expression products
EP2620446A1 (en) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
DE102013004595A1 (de) 2013-03-15 2014-09-18 Emergent Product Development Germany Gmbh RSV-Impfstoffe
ES2944314T3 (es) 2016-01-08 2023-06-20 Geovax Inc Composiciones y procedimientos para generar una respuesta inmunitaria frente a un antígeno asociado a un tumor
AU2020384323A1 (en) 2019-11-14 2022-06-02 Aelix Therapeutics, S.L. Dosage regimens for vaccines
KR20220154114A (ko) 2020-02-14 2022-11-21 지오박스, 인크. 백신 및 SARS-CoV2에 대한 면역 반응을 유도하기 위한 그의 용도
WO2021260065A1 (en) 2020-06-24 2021-12-30 Consejo Superior De Investigaciones Científicas (Csic) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP3928789A1 (en) 2020-06-24 2021-12-29 Consejo Superior de Investigaciones Científicas (CSIC) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP4358999A1 (en) 2021-06-23 2024-05-01 Consejo Superior De Investigaciones Científicas Mva-based vaccine expressing a prefusion-stabilized sars-cov-2 s protein
EP4108257A1 (en) 2021-06-23 2022-12-28 Consejo Superior De Investigaciones Científicas Mva-based vaccine against covid-19 expressing a prefusion-stabilized sars-cov-2 s protein

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152745B (da) * 1977-04-01 1988-05-09 Anton Mayr Fremgangsmaade ved fremstilling af et praeparat til behandling af herpes zoster og andre herpesinfektioner

Also Published As

Publication number Publication date
ES406590A1 (es) 1975-09-16
BE787901A (fr) 1972-12-18
AT320149B (de) 1975-01-27
CH568392A5 (da) 1975-10-31
DK137392C (da) 1978-09-18
DE2145477A1 (de) 1973-03-15
DE2145477B2 (de) 1976-04-01

Similar Documents

Publication Publication Date Title
DK137392B (da) Fremgangsmade til fremstilling af en koppebeskyttelsesvaccine i form af svekket vaccinia-vira til brug ved forvaccination inden den egentlige koppevaccination
DK114429B (da) Fremsgangmåde til fremstilling af et med kontrolleret frigørelse virkende terapeutisk præparat til oral brug.
DK145283C (da) Vaccine til forhindring af graviditet og fremgangsmaade til fremstilling af vaccinen
DK143689C (da) Fremgangsmaade til fremstilling af en adsorberet vaccine
DK138695C (da) Fremgangsmaade til fremstilling af pyrrolidon-5,5-difosfonsyrer og vandoploeselige salte heraf
DK114289B (da) Fremgangsmåde til fremstilling af en inaktiveret vaccine mod svinekolera.
SE7604818L (sv) Vaccin
IT953555B (it) Procedimento e apparecchiatura per preparare tratti misurati di bava serica dentale
DK401575A (da) Cis-decahydroisoquinolin-analgetika og fremgangsmade til deres fremstilling
DK131609C (da) Fremgangsmade til fremstilling af en mod marek's sygdom aktivvaccine
AT282824B (de) Verfahren zur Herstellung einer neuen Adjuvansvaccine
CS191868B2 (en) Method of preparing live virus vaccine
DK157032C (da) Fremgangsmaade til fremstilling af en vandig bitumenholdig emulsion
NL7607958A (nl) Nieuw rabies virusvaccin en werkwijze ter bereiding daarvan.
TR19668A (tr) Cinko buharinin yogunlastirilmasi
IT1043894B (it) Vaccino morto contro rinite atrcfica infettiva dei suini e procedimento per la sua preparazione
BE794307A (fr) Vaccin anti-caries
AT352258B (de) Kupplung fuer zahnaerztliche handstuecke
DK132447C (da) Fremgangsmade til fremstilling af kalvediarrevirusvaccine
FI41428C (fi) Influenssa-rokotteen valmistusmenetelmä
BE781028R (fr) Adjuvants pour vaccins et preparations de vaccins les
DK119939B (da) Fremgangsmåde til fremstilling af tetanus-vaccine.
IT971549B (it) Procedimento per la preparazione di telomeri perfluoroalchiliodi drici
SE424503B (sv) Forfarande for framstellning av levande influensavirusvaccin typ b
AR201878A1 (es) Procedimiento para preparar una vacuna inmunizante y no patogena